Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Functional Signatures Revealed By Deep Phenotyping of CMV-Specific CD8+ T Cells Predict Risk of Early CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation

Jose F Camargo, MD, Eric Wieder, PhD, Erik Kimble, MD, Cara Benjamin, PhD, Despina Kolonias, Gabriela Bravo, MD, Krishna Komanduri, MD

Blood (2017) 130 (Supplement 1): 746.

https://doi.org/10.1182/blood.V130.Suppl_1.746.746

Published: 2017

Journal Articles

Peripheral Tolerance to PR1 Is Maintained After Uptake of Soluble Proteinas-3 and Neutrophil Elastase

Gheath Alatrash, DO, PhD, Yoko Ono, MD, Anna Sergeeva, PhD, Pariya Sukhumalchandra, BS, Mao Zhang, MPH, Kathryn Quintanilla, MS, Paul Armistead, MD, PhD, Hong He, MD, Tania Rodriguez-Cruz, BS, Karen Clise-Dwyer, PhD, Eric Wieder, PhD, Greg Lizee, PhD, Sijie Lu, PhD, Jeffrey J. Molldrem, MD

Blood (2010) 116 (21): 4301.

https://doi.org/10.1182/blood.V116.21.4301.4301

Published: 2010

Journal Articles

T-Cell Autoimmunity May Contribute to Neutropenia in a Patient with Cyclic Neutropenia (CN) and Double De-Novo Mutations in Gfi-1.

Paul M. Armistead, MD, PhD, Eric Wieder, PhD, Olanike Akande, MS, Jeffrey J. Molldrem, MD

Blood (2007) 110 (11): 3298.

https://doi.org/10.1182/blood.V110.11.3298.3298

Published: 2007

Journal Articles

Pre-Existing Anti-GM-CSF Autoantibodies in Patients with AML, CML and MDS Are Associated with Compromised Immune Response to PR1 Peptide Vaccination.

Anna Sergeeva, PhD, Eric Wieder, PhD, Nancy Milam, Yoko Ono, MD, Rosa Rios, Jeffrey J. Molldrem, MD

Blood (2005) 106 (11): 3257.

https://doi.org/10.1182/blood.V106.11.3257.3257

Published: 2005

Journal Articles

PR1 Leukemia-Associated Antigen Is Cross-Presented by B Cells from Soluble Serum Proteases.

Yoko Ono, MD, Sijie Lu, PhD, Anna Sergeeva, PhD, Changqing Wang, Eric Wieder, PhD, Jeffrey J. Molldrem, MD

Blood (2005) 106 (11): 2397.

https://doi.org/10.1182/blood.V106.11.2397.2397

Published: 2005

Journal Articles

High Avidity Cyclin E-Derived Peptide-Specific CTL Contribute to Induction of Remission after Stem Cell Transplantation without Associated Graft-Versus-Host Disease.

Ken Ishiyama, MD, Yukio Kondo, MD, Eric Wieder, PhD, Sijie Lu, PhD, Jeffrey Molldrem, MD

Blood (2005) 106 (11): 1424.

https://doi.org/10.1182/blood.V106.11.1424.1424

Published: 2005

Journal Articles

Vaccination with the PR1 Leukemia-Associated Antigen Can Induce Complete Remission in Patients with Myeloid Leukemia.

Muzaffar H. Qazilbash, MD, Eric Wieder, PhD, Rosa Rios, Sijie Lu, Shreya Kant, Sergio Giralt, MD, Elihu H. Estey, MD, Peter Thall, Marcos de Lima, MD, Daniel Couriel, MD, Richard E. Champlin, MD, Krishna Komanduri, MD, Jeffrey J. Molldrem, MD

Blood (2004) 104 (11): 259.

https://doi.org/10.1182/blood.V104.11.259.259

Published: 2004

NARROW

Functional Signatures Revealed By Deep Phenotyping of CMV-Specific CD8+ T Cells Predict Risk of Early CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation

Peripheral Tolerance to PR1 Is Maintained After Uptake of Soluble Proteinas-3 and Neutrophil Elastase

T-Cell Autoimmunity May Contribute to Neutropenia in a Patient with Cyclic Neutropenia (CN) and Double De-Novo Mutations in Gfi-1.

Pre-Existing Anti-GM-CSF Autoantibodies in Patients with AML, CML and MDS Are Associated with Compromised Immune Response to PR1 Peptide Vaccination.

PR1 Leukemia-Associated Antigen Is Cross-Presented by B Cells from Soluble Serum Proteases.

High Avidity Cyclin E-Derived Peptide-Specific CTL Contribute to Induction of Remission after Stem Cell Transplantation without Associated Graft-Versus-Host Disease.

Vaccination with the PR1 Leukemia-Associated Antigen Can Induce Complete Remission in Patients with Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Functional Signatures Revealed By Deep Phenotyping of CMV-Specific CD8+ T Cells Predict Risk of Early CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation

Peripheral Tolerance to PR1 Is Maintained After Uptake of Soluble Proteinas-3 and Neutrophil Elastase

T-Cell Autoimmunity May Contribute to Neutropenia in a Patient with Cyclic Neutropenia (CN) and Double De-Novo Mutations in Gfi-1.

Pre-Existing Anti-GM-CSF Autoantibodies in Patients with AML, CML and MDS Are Associated with Compromised Immune Response to PR1 Peptide Vaccination.

PR1 Leukemia-Associated Antigen Is Cross-Presented by B Cells from Soluble Serum Proteases.

High Avidity Cyclin E-Derived Peptide-Specific CTL Contribute to Induction of Remission after Stem Cell Transplantation without Associated Graft-Versus-Host Disease.

Vaccination with the PR1 Leukemia-Associated Antigen Can Induce Complete Remission in Patients with Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only